As we wrap up 2024, the IMPALA Consortium reflects on a year of significant progress and achievements in its mission to transform quality in biopharma through the implementation of advance analytics. This year has been marked by impactful work products, [...]
IMPALA is pleased to share it's newest published article in RQA QUASAR #169, November 2024 - Transforming Trial Audits: A Deep Dive Into Data-Driven Clinical Site Audit Selection in Pharmaceuticals. The paper was led by the Audit Site Selection Work Product [...]
IMPALA Consortium is pleased to release the recording from the Research Quality Association (RQA) Quality Conversation session on August 27, 2024. The session highlights include an introduction to IMPALA Consortium and its innovative open-source tools, an in-depth review of the [...]
IMPALA is pleased to share our latest work product "Data Analytics for Quality Assurance in Pharmaceutical Development Framework," which offers insights and guidance on transforming Quality Assurance (QA) in Good Clinical Practice (GCP) and Good Pharmacovigilance Practice (GVP) through the [...]
The Drug Information Association (DIA) Global Annual Meeting held in San Diego from June 17-20, 2024, brought together professionals from the pharmaceutical industry, regulatory agencies, and research organizations. We were lucky to have a great delegation of IMPALA (Inter coMPany [...]
